Norovirus Treatment: Managing Illness at Home
There is no approved antiviral medication for norovirus. Treatment is supportive — replacing fluids, resting, and preventing spread to others.
No Approved Antiviral for Norovirus
As of 2026, there is no FDA-approved antiviral medication that specifically treats norovirus infection. Antibiotics are not effective against viral infections and should not be taken for norovirus illness. Treatment is supportive and focused on preventing dehydration.
The Priority: Oral Rehydration
Dehydration — not the virus itself — is the most dangerous consequence of norovirus illness. The CDC and WHO both prioritize oral rehydration as the cornerstone of norovirus management.
Oral Rehydration Solutions (ORS)
Per WHO guidance, oral rehydration solutions contain a specific balance of glucose, sodium, and potassium that promotes intestinal absorption of fluid far more effectively than plain water or sports drinks.
- Commercial ORS (Pedialyte, Ceralyte, Enfalyte): Recommended for children and adults; available without prescription
- WHO Oral Rehydration Salts: Available globally; ideal sodium-to-glucose ratio for maximum absorption
- Avoid exclusively plain water during active diarrhea and vomiting — it does not replace electrolytes and can worsen electrolyte imbalance in infants
- Avoid sugary drinks, juice, and sports drinks for young children — high sugar content can worsen diarrhea
How to Rehydrate When Vomiting
- Wait 30–60 minutes after the last vomiting episode before attempting fluids
- Start with very small amounts: 1–2 teaspoons (5–10 mL) every 5 minutes
- Gradually increase the amount if tolerated — progress to 30 mL every 15 minutes, then larger amounts as tolerated
- If vomiting recurs, wait another 30–60 minutes and start again from small amounts
- Popsicles made from ORS solutions can be easier to tolerate than drinking from a cup
Symptom Management
| Symptom | Management | Notes |
|---|---|---|
| Nausea / Vomiting | Rest, small fluid sips; OTC antiemetics (e.g., dimenhydrinate) may reduce discomfort | Antiemetics do not treat the infection; consult a pharmacist before use in children |
| Diarrhea | Loperamide (Imodium) may reduce episodes in adults | Not recommended for children under 12 without physician guidance; do not use if fever or bloody stool is present |
| Stomach cramping | Heating pad on low setting for comfort; antispasmodics rarely needed | Cramping typically resolves as diarrhea and vomiting subside |
| Fever and body aches | Acetaminophen (Tylenol) or ibuprofen (Advil) per package directions | Avoid aspirin in children under 18 (Reye's syndrome risk) |
| Fatigue | Rest; do not force activity; resume normal diet gradually | Fatigue can persist 1–2 days after acute symptoms resolve |
Returning to Eating
Per CDC guidance, there is no strict requirement to follow the outdated "BRAT diet" (bananas, rice, applesauce, toast) for norovirus recovery. Current guidance recommends returning to a normal, balanced diet as tolerated, which supports faster intestinal recovery than prolonged bland diets.
- Begin with small amounts of easy-to-digest foods: crackers, toast, plain rice, bananas
- Avoid fatty, spicy, or heavily seasoned foods initially — they can worsen nausea
- Avoid dairy products for 24–48 hours if they seem to worsen diarrhea (temporary lactose intolerance can occur during acute illness)
- Progress to normal meals as tolerated, usually within 24–48 hours of symptom resolution
When to Seek Medical Care
Seek Care Immediately For:
- Signs of severe dehydration: inability to urinate, extreme dry mouth, sunken eyes, confusion, rapid heartbeat
- Blood in stool or vomit
- Fever above 102°F (38.9°C) persisting more than 24 hours
- Symptoms lasting more than 3 days without improvement in otherwise healthy adults
- Any norovirus illness in an infant under 3 months
- Anyone who is immunocompromised, pregnant, or has kidney disease with prolonged symptoms
IV Rehydration
Patients who cannot tolerate oral fluids or who present with severe dehydration may require intravenous (IV) fluid replacement in a clinical setting. This is typically a short-term intervention — once the patient can tolerate oral fluids, they can usually be discharged home.
Antiviral Research Status
As of 2026, several antiviral compounds targeting norovirus are in various stages of clinical development. Nitazoxanide has shown modest activity in some studies. Favipiravir and other broad-spectrum antivirals have been investigated in preclinical and early-phase studies. No compound has achieved Phase III trial success sufficient for regulatory approval. Vaccine candidates are advancing through clinical trials (see the Outbreaks page for research updates).
Until an approved therapy becomes available, supportive care and aggressive oral rehydration remain the standard of care per CDC and WHO guidelines.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical decisions.
